Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease.

Frank Geurts Layal Chaker Anna C van der Burgh Deirdre P Cronin-Fenton Robert A Fenton Ewout J Hoorn

Published in: Journal of the American Heart Association (2024)

Urinary PGE2 and PGEM excretions are novel markers for the presence and progression of cardiovascular and kidney disease. Future studies should address whether these associations are causal and can be targeted to improve cardiovascular and kidney outcomes.

Keyphrases

type diabetes
current status
cancer therapy
metabolic syndrome
drug delivery